DE69404451D1 - Prüfung zur vorhersage des ergebnisses von ivf - Google Patents

Prüfung zur vorhersage des ergebnisses von ivf

Info

Publication number
DE69404451D1
DE69404451D1 DE69404451T DE69404451T DE69404451D1 DE 69404451 D1 DE69404451 D1 DE 69404451D1 DE 69404451 T DE69404451 T DE 69404451T DE 69404451 T DE69404451 T DE 69404451T DE 69404451 D1 DE69404451 D1 DE 69404451D1
Authority
DE
Germany
Prior art keywords
beta
ivf
hsd
pct
date sep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69404451T
Other languages
English (en)
Other versions
DE69404451T2 (de
Inventor
Brian Department Of Bioc Cooke
Anthony Department Of Michael
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Royal Free Hospital School of Medicine
Original Assignee
Royal Free Hospital School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Free Hospital School of Medicine filed Critical Royal Free Hospital School of Medicine
Application granted granted Critical
Publication of DE69404451D1 publication Critical patent/DE69404451D1/de
Publication of DE69404451T2 publication Critical patent/DE69404451T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/806—Fertility tests
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE69404451T 1993-03-23 1994-03-23 Prüfung zur vorhersage des ergebnisses von ivf Expired - Fee Related DE69404451T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939305984A GB9305984D0 (en) 1993-03-23 1993-03-23 Predictive assay
PCT/GB1994/000596 WO1994021815A1 (en) 1993-03-23 1994-03-23 Predictive assay for the outcome of ivf

Publications (2)

Publication Number Publication Date
DE69404451D1 true DE69404451D1 (de) 1997-08-28
DE69404451T2 DE69404451T2 (de) 1997-12-04

Family

ID=10732572

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69404451T Expired - Fee Related DE69404451T2 (de) 1993-03-23 1994-03-23 Prüfung zur vorhersage des ergebnisses von ivf

Country Status (10)

Country Link
US (1) US5635366A (de)
EP (1) EP0690925B1 (de)
JP (1) JP3429311B2 (de)
AT (1) ATE155820T1 (de)
DE (1) DE69404451T2 (de)
DK (1) DK0690925T3 (de)
ES (1) ES2106517T3 (de)
GB (1) GB9305984D0 (de)
GR (1) GR3025000T3 (de)
WO (1) WO1994021815A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965372A (en) * 1995-08-24 1999-10-12 Baker Medical Research Institute Genetic sequences encoding glucocorticoid dehydrogenases and uses thereof
US5883240A (en) * 1995-08-24 1999-03-16 Baker Medical Research Institute Genetic sequences encoding glucocorticoid dehydrogenases and uses therefor
GB9603326D0 (en) * 1996-02-16 1996-04-17 Royal Free Hosp School Med Predictive assay
US20030124640A1 (en) * 1996-02-16 2003-07-03 Royal Free Hospital School Of Medicine Predictive assay for the outcome of IVF
US5994148A (en) * 1997-06-23 1999-11-30 The Regents Of University Of California Method of predicting and enhancing success of IVF/ET pregnancy
EP3498827A1 (de) 2004-05-17 2019-06-19 The General Hospital Corporation Zusammensetzungen mit weiblichen keimbahnstammzellen und verfahren zur verwendung davon
US8024128B2 (en) * 2004-09-07 2011-09-20 Gene Security Network, Inc. System and method for improving clinical decisions by aggregating, validating and analysing genetic and phenotypic data
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US20070027636A1 (en) * 2005-07-29 2007-02-01 Matthew Rabinowitz System and method for using genetic, phentoypic and clinical data to make predictions for clinical or lifestyle decisions
US10083273B2 (en) 2005-07-29 2018-09-25 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10081839B2 (en) 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
US8532930B2 (en) 2005-11-26 2013-09-10 Natera, Inc. Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals
US20070178501A1 (en) * 2005-12-06 2007-08-02 Matthew Rabinowitz System and method for integrating and validating genotypic, phenotypic and medical information into a database according to a standardized ontology
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US8515679B2 (en) * 2005-12-06 2013-08-20 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
CA2632230C (en) 2005-11-26 2019-05-07 Gene Security Network, Inc. System and method for cleaning noisy genetic data and using genetic, phentoypic and clinical data to make predictions
US20110033862A1 (en) * 2008-02-19 2011-02-10 Gene Security Network, Inc. Methods for cell genotyping
US20110092763A1 (en) * 2008-05-27 2011-04-21 Gene Security Network, Inc. Methods for Embryo Characterization and Comparison
AU2009279734A1 (en) 2008-08-04 2010-02-11 Natera, Inc. Methods for allele calling and ploidy calling
WO2011041485A1 (en) 2009-09-30 2011-04-07 Gene Security Network, Inc. Methods for non-invasive prenatal ploidy calling
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
EP2572003A4 (de) 2010-05-18 2016-01-13 Natera Inc Verfahren zur nichtinvasiven pränatalen ploidiezuordnung
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
CA2821906C (en) 2010-12-22 2020-08-25 Natera, Inc. Methods for non-invasive prenatal paternity testing
BR112013020220B1 (pt) 2011-02-09 2020-03-17 Natera, Inc. Método para determinar o estado de ploidia de um cromossomo em um feto em gestação
EA201391523A1 (ru) 2011-04-14 2014-03-31 Зе Дженерэл Хоспитэл Корпорейшн Композиции и способы для переноса энергии митохондрий аутологичных герминативных клеток
EP2726601B1 (de) 2011-06-29 2018-12-26 The General Hospital Corporation Zusammensetzungen und verfahren zur verbesserung des bioenergetischen status bei weiblichen keimzellen
SI2742359T1 (en) 2011-08-12 2018-08-31 Artpred B.V. A new procedure and a set of in vitro fertilization in vitro predictors
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
WO2015048535A1 (en) 2013-09-27 2015-04-02 Natera, Inc. Prenatal diagnostic resting standards
AU2015249846B2 (en) 2014-04-21 2021-07-22 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
EP4428863A2 (de) 2015-05-11 2024-09-11 Natera, Inc. Verfahren und zusammensetzungen zur bestimmung der ploidie
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
CA3049139A1 (en) 2017-02-21 2018-08-30 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
WO2019118926A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
EP3781714A1 (de) 2018-04-14 2021-02-24 Natera, Inc. Verfahren zur krebserkennung und -überwachung durch personalisierte detektion zirkulierender tumor-dna
US11525159B2 (en) 2018-07-03 2022-12-13 Natera, Inc. Methods for detection of donor-derived cell-free DNA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5173404A (en) * 1983-03-15 1992-12-22 University Of Southern California Immunoassay for follicular regulatory protein
ES294191Y (es) * 1986-05-16 1987-06-16 Ortueta Corona L Fernand Aparato optico, consistente en un microscopio de 100x llevando incorporado una linterna de 1,5 v

Also Published As

Publication number Publication date
GR3025000T3 (en) 1998-01-30
JPH08507924A (ja) 1996-08-27
DK0690925T3 (da) 1997-09-22
WO1994021815A1 (en) 1994-09-29
EP0690925B1 (de) 1997-07-23
DE69404451T2 (de) 1997-12-04
EP0690925A1 (de) 1996-01-10
ATE155820T1 (de) 1997-08-15
GB9305984D0 (en) 1993-05-12
JP3429311B2 (ja) 2003-07-22
US5635366A (en) 1997-06-03
ES2106517T3 (es) 1997-11-01

Similar Documents

Publication Publication Date Title
DE69404451D1 (de) Prüfung zur vorhersage des ergebnisses von ivf
SE9504046D0 (sv) Method of determining affinity and kinetic properties
GB8916400D0 (en) Modified igg3
ATE397891T1 (de) Methode und apparat zur konservierung von speichel für analysen
IL106698A0 (en) Diagnostic method, and kit and antibodies therefor
EP2306192A3 (de) Risikomarker für eine Herzkreislaufkrankheit
ATE258310T1 (de) Testverfahren für collagenpeptid
WO2000018954A3 (en) Use of pex in the treatment of metabolic bone diseases
MX2023006598A (es) Biomarcadores agonistas del trem2 y métodos para usarlos.
SE9403833D0 (sv) Analysförfarande och kit
DK0929809T3 (da) Fremgangsmåde og apparat til in vitro diagnose af allergiske lidelser
AU4711597A (en) Diagnosis of spongiform encephalopathy
NO930705L (no) Fremgangsmaate for bestemmelse av en vannbehandlingspolymer i en vandig proeve
DK0791073T3 (da) Analysemetode
DE60035267D1 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
RS20060255A (en) Quick test for the diagnosis of alzheimer's disease
DK0824696T3 (da) Fremgangsmåde og kit til at forudsige den terapeutiske reaktion på et medikament mod en malign tumor
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
DE50303798D1 (de) Vorrichtung, um in einem Zielgebiet eines menschlichen oder tierischen Körpers einen künstlichen isolierten Kreislauf zu etablieren
Noppinger et al. An evaluation of an enzymatic choline determination for the identification of semen in casework samples
DK0587090T3 (da) Fremgangsmåde til bestemmelse af thromboseforårsagende lupus-antikoagulat-antistoffer.
DE69618451D1 (de) Verfahren zur feststellung einer allergie
DE69227623D1 (de) Verfahren zum Nachweis einer CMV-Infektion
DE59403993D1 (de) Verfahren zur stabilisierung von osteocalcin in humanen serums- oder plasmaproben für die bestimmung des osteocalcingehalts sowie instrumente und probengefässe zur durchführung dieses verfahrens
EP1436624A4 (de) Diagnose- und behandlungsverfahren sowie dafür geeignete mittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee